◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › AKAN

Akanda Corp. (AKAN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-07-26

Akanda Corp. (AKAN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Toronto, Canada. Its market capitalization is roughly $4 million. In the fiscal year ended 2025-12-31, AKAN reported $0M in revenue and ($46M) in net income.

Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.

Interactive charts & full statements → Open the AKAN valuation workbench →

AKAN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total Revenue$0M$0M$0M$3M
Gross Profit($0M)$0M$0M$3M
Operating Income (EBIT)($5M)($4M)($4M)($20M)
Net Income($46M)($4M)($32M)($12M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AKAN Free Cash Flow History

AKAN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$6M$8M$9M$39M
Total Liabilities$18M$4M$13M$12M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AKAN viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← AKAMAll stocksAKBA →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.